Literature DB >> 16849357

Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.

T J Borody, L B Heifets.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16849357      PMCID： PMC1856296     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?

Authors:  T J Borody; S Leis; E F Warren; R Surace
Journal:  Dig Liver Dis       Date:  2002-01       Impact factor: 4.088

2.  Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

Authors:  Saleh A Naser; George Ghobrial; Claudia Romero; John F Valentine
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

3.  Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.

Authors:  Tim J Bull; Elizabeth J McMinn; Karim Sidi-Boumedine; Angela Skull; Damien Durkin; Penny Neild; Glenn Rhodes; Roger Pickup; John Hermon-Taylor
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Tubercle       Date:  1987-12

5.  Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up.

Authors:  P R Salmon; P Brown; R Williams; A E Read
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

Review 7.  Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease.

Authors:  Robert J Greenstein
Journal:  Lancet Infect Dis       Date:  2003-08       Impact factor: 25.071
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.